Spanish Validation of the Syndrom Kurztest (SKT)

Fornazzari, Luis; Cumsille, Francisco; Quevedo, Fernando; Quiroga, Pilar; Rioseco, Pedro; Klaasen, G.; Martínez, Carmelo Gómez; Rhode, G.; Sacks, Claudio; Rivera, Elisabet; Gassic, I.; F, Hammersley; Hoppe, A.; Arriagada, Pablo; Flaskamp, R.

doi:10.1097/00002093-200110000-00007

Cited by 16 publications

(10 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Originally the SKT was introduced in Germany; however, the test has been translated and validated in English and other languages [10,14,15]. It has been shown in neurological patients to mirror excellently the course of early and moderate severe dementia and to be sensitive to therapy in these stages.…”

Section: Methodsmentioning

confidence: 99%

Psychomotor dysfunction after remifentanil/propofol anaesthesia

Dressler¹,

Fritzsche²,

Cortina

et al. 2007

European Journal of Anaesthesiology

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Psychomotor dysfunction after remifentanil/propofol anaesthesia

Dressler¹,

Fritzsche²,

Cortina

et al. 2007

European Journal of Anaesthesiology

View full text Add to dashboard Cite

show abstract

“…The Syndrom Kurztest reference consists of 9 timed subtests that assess memory, attention, naming and object arrangement. The Syndrom Kurztest was validated and standardized in a population of elderly Chileans [22]. The Short Blessed Test is an abridged version of the 26-item Blessed Test of Information-Memory-Concentration.…”

Section: Memorymentioning

confidence: 99%

Prevalence of Mild Cognitive Impairment and Its Subtypes in the Mexican Population

Juárez‐Cedillo

Sánchez-Arenas

Sánchez-García

et al. 2012

Dement Geriatr Cogn Disord

View full text Add to dashboard Cite

Background/Aim: To estimate the prevalence of mild cognitive impairment (MCI) and its subtypes, taking into account education and health status. Methods: This is the first report of our Study on Aging and Dementia in Mexico. This study included 2,944 elderly individuals 60 years old or more with in-home assessment for cognitive impairment. The prevalence of MCI was based on Petersen criteria. MCI was classified as amnestic of single domain (a-MCI-s) or multiple domain (a-MCI-md) or nonamnestic of single domain (na-MCI-s) or multiple domain (na-MCI-md). In addition to a battery of neuropsychological measures, a self-report depression measure and a medical history including history of stroke, heart disease and other health conditions were recorded. Results: The global estimated prevalence of MCI in the Mexican population was 6.45%. Of these subjects, 2.41% met criteria for a-MCI-s, 2.56% for a-MCI-md, 1.18% for na-MCI-s and 0.30% for na-MCl-md. Women showed a higher prevalence of MCI than men (63.7 vs. 36.3%, respectively). The analysis showed that heart disease [odds ratio (OR) 1.5], stroke (OR 1.2) and depression (OR 2.1) were associated with an increased risk of MCI. Conclusions: The prevalence of MCI in Mexico is similar to that in other countries. The results suggest that stroke, heart disease and depression may have an important role in the etiology of MCI.

show abstract

“…A final remark refers to the international validity of the SKT, which up to about 1990 was mainly used in German-speaking countries. However, in the following years an increasing number of international studies were performed, e.g., in the United States, the UK, Greece, Russia, Chile, Mexico, Brazil or South Korea [44][45][46][47][48][49][50]. Some of these studies specifically aimed at validating the SKT for the respective target language or culture.…”

Section: Discussionmentioning

confidence: 99%

The Newly Normed SKT Reveals Differences in Neuropsychological Profiles of Patients with MCI, Mild Dementia and Depression

Lehfeld

Stemmler

2019

Diagnostics

View full text Add to dashboard Cite

The SKT (Syndrom-Kurztest) is a short cognitive performance test assessing deficits of memory and attention in the sense of speed of information processing. The new standardization of the SKT (2015) aimed at improving its sensitivity for early cognitive decline due to dementia in subjects aged 60 or older. The goal of this article is to demonstrate how the neuropsychological test profile of the SKT can be used to provide valuable information for a differential diagnosis between MCI (mild cognitive impairment), dementia and depression. n = 549 patients attending a memory clinic (Nuremberg, Germany) were diagnosed according to ICD-10 and tested with the SKT. The SKT consists of nine subtests, three for the assessment of memory and six for measuring attention in the sense of speed of information processing. The result of the SKT test procedure is a total score, which indicates the severity of overall cognitive impairment. Besides the summary score, two subscores for memory and attention can be interpreted. Using the level of depression as a covariate, statistical comparisons of SKT test profiles between the three patient groups revealed that depressed patients showed more pronounced deficits than MCI patients in all six attention subtests. On the other hand, MCI patients displayed significantly greater mnestic impairment than the depressed group, which was indicated by significant differences in the memory subscore. MCI and dementia patients showed similar deficit patterns dominated by impairment of memory (delayed recall) with MCI patients demonstrating less overall impairment. In sum, the SKT neuropsychological test profiles provided indicators for a differential diagnosis between MCI and beginning dementia vs. depression.

show abstract

Spanish Validation of the Syndrom Kurztest (SKT)

Cited by 16 publications

References 9 publications

Psychomotor dysfunction after remifentanil/propofol anaesthesia

Psychomotor dysfunction after remifentanil/propofol anaesthesia

Prevalence of Mild Cognitive Impairment and Its Subtypes in the Mexican Population

The Newly Normed SKT Reveals Differences in Neuropsychological Profiles of Patients with MCI, Mild Dementia and Depression

Contact Info

Product

Resources

About